Clementia gets Orphan Medicinal Product Designation from EMA for palovarotene Clementia Pharmaceuticals, Inc generic . Announced today that the European Medications Agency provides granted Orphan Medicinal Product Designation for palovarotene, the organization's lead item candidate, for the treatment of fibrodysplasia ossificans progressiva . FOP is a rare, disabling genetic disease seen as a painful severely, recurrent episodes of gentle tissue swelling and new abnormal bone formation. This process, known as heterotopic ossification , happens in muscles, ligaments and tendons, leading to significant morbidities and progressive disability.

The Daily Health Policy Report is released for, a free assistance of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Board Firm and Kaiser Family Base. All rights reserved.. Cleveland Clinic to provide heart care in Chicago; Johns Hopkins raises primary treatment in D.C. Area Chicago Tribune: In a move more likely to shake up the market for heart care in the Chicago area, the Cleveland Clinic’s cardiac surgery program has signed an affiliation agreement with Central DuPage Hospital in west suburban Winfield. The offer, announced Thursday, is made to improve the heart treatment provided at the 313-bed hospital and potentially bring Cleveland Clinic patient referrals at the same time when fewer heart surgeries are needed than were ten years ago. Heart care typically is usually a hospital’s most lucrative service, drawing tens of huge amount of money to the average community medical center.